Estimates Revisions Jasper Therapeutics, Inc.
Stocks
JSPR
US4718712023
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6208 USD | +3.45% |
|
-14.85% | -66.08% |
| 07-17 | Jasper Therapeutics, Inc. Announces Board, Committee and Executive Changes, Effective July 16, 2026 | CI |
| 07-16 | Jasper Therapeutics Completes Merger With Kira Pharmaceuticals, Shares Fall | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | - | ||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- JSPR Stock
- Consensus Jasper Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
